pubmed-article:19997092 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19997092 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
pubmed-article:19997092 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:19997092 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:19997092 | lifeskim:mentions | umls-concept:C0175795 | lld:lifeskim |
pubmed-article:19997092 | lifeskim:mentions | umls-concept:C1955832 | lld:lifeskim |
pubmed-article:19997092 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:19997092 | pubmed:dateCreated | 2010-3-5 | lld:pubmed |
pubmed-article:19997092 | pubmed:abstractText | Adherence is generally associated with improved treatment outcomes. Risk factors for non-adherence must be understood to improve adherence. A systematic review was undertaken to determine which variables were consistently associated with non-adherence to oral medication in inflammatory bowel disease (IBD). | lld:pubmed |
pubmed-article:19997092 | pubmed:language | eng | lld:pubmed |
pubmed-article:19997092 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997092 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19997092 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997092 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19997092 | pubmed:month | Mar | lld:pubmed |
pubmed-article:19997092 | pubmed:issn | 1572-0241 | lld:pubmed |
pubmed-article:19997092 | pubmed:author | pubmed-author:RobinsonAA | lld:pubmed |
pubmed-article:19997092 | pubmed:author | pubmed-author:JacksonC ACA | lld:pubmed |
pubmed-article:19997092 | pubmed:author | pubmed-author:ClatworthyJJ | lld:pubmed |
pubmed-article:19997092 | pubmed:author | pubmed-author:HorneRobR | lld:pubmed |
pubmed-article:19997092 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19997092 | pubmed:volume | 105 | lld:pubmed |
pubmed-article:19997092 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19997092 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19997092 | pubmed:pagination | 525-39 | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:meshHeading | pubmed-meshheading:19997092... | lld:pubmed |
pubmed-article:19997092 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:19997092 | pubmed:articleTitle | Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. | lld:pubmed |
pubmed-article:19997092 | pubmed:affiliation | Department of Practice and Policy, University of London, London, UK. christina.jackson@pharmacy.ac.uk | lld:pubmed |
pubmed-article:19997092 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19997092 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:19997092 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |